ARCH Venture Partners XII, LLC - 10%+ Owner at Neumora Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
NMRA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

ARCH Venture Partners XII, LLC - trading volume in the past year for Neumora Therapeutics, Inc.

Holdings reported by ARCH Venture Partners XII, LLC for Neumora Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 12.2M $146M $11.98 Dec 8, 2023 By ARCH Venture Fund X, L.P.
Common Stock 11.9M $142M $11.98 Dec 8, 2023 By ARCH Venture Fund X Overage, L.P.
Common Stock 4.13M $49.5M $11.98 Dec 8, 2023 By ARCH Venture Fund XII, L.P.
Common Stock 2.32M $27.8M $11.98 Dec 8, 2023 By ARCH Venture Fund VIII Overage, L.P.
Common Stock 1.39M $16.6M $11.98 Dec 8, 2023 By ARCH Venture Fund VII, L.P.

Transactions reported by ARCH Venture Partners XII, LLC for Neumora Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.